IL97233A - Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them - Google Patents

Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them

Info

Publication number
IL97233A
IL97233A IL9723391A IL9723391A IL97233A IL 97233 A IL97233 A IL 97233A IL 9723391 A IL9723391 A IL 9723391A IL 9723391 A IL9723391 A IL 9723391A IL 97233 A IL97233 A IL 97233A
Authority
IL
Israel
Prior art keywords
analog
rebeccamycin
compound
formula
fluorotryptophan
Prior art date
Application number
IL9723391A
Other languages
English (en)
Hebrew (he)
Other versions
IL97233A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL97233A0 publication Critical patent/IL97233A0/xx
Publication of IL97233A publication Critical patent/IL97233A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ceramic Products (AREA)
IL9723391A 1990-03-06 1991-02-14 Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them IL97233A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48943090A 1990-03-06 1990-03-06
US64875191A 1991-02-05 1991-02-05

Publications (2)

Publication Number Publication Date
IL97233A0 IL97233A0 (en) 1992-05-25
IL97233A true IL97233A (en) 1995-03-30

Family

ID=27049711

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9723391A IL97233A (en) 1990-03-06 1991-02-14 Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them

Country Status (22)

Country Link
US (1) US5468849A (da)
EP (1) EP0450327B1 (da)
JP (1) JPH0780899B2 (da)
KR (1) KR940005657B1 (da)
AT (1) ATE138926T1 (da)
AU (1) AU623050B2 (da)
CY (1) CY1941A (da)
CZ (1) CZ279307B6 (da)
DE (1) DE69119964T2 (da)
DK (1) DK0450327T3 (da)
ES (1) ES2088439T3 (da)
FI (1) FI102376B1 (da)
GR (1) GR3020163T3 (da)
HK (1) HK181496A (da)
HU (1) HU211055B (da)
IE (1) IE910737A1 (da)
IL (1) IL97233A (da)
NO (1) NO179555C (da)
PT (1) PT96943B (da)
SG (1) SG63555A1 (da)
TW (1) TW232698B (da)
YU (1) YU39391A (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
EP0630242B1 (en) * 1992-03-20 1999-01-20 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
WO1995034663A1 (fr) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene codant la glycosyl-transferase et utilisation de ce gene
AU710669B2 (en) * 1996-08-22 1999-09-23 Bristol-Myers Squibb Company Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
YU74103A (sh) * 2001-03-22 2006-05-25 Bristol-Myers Squibb Company Topoizomeraza i selektivni citotoksični šećerni derivati indolopirolokarbazola

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4487925A (en) 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
US4567143A (en) * 1984-09-04 1986-01-28 Bristol-Myers Company Process for preparing 4'-deschlororebeccamycin
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
AU623050B2 (en) 1992-04-30
FI911047A0 (fi) 1991-03-01
NO179555C (no) 1996-10-30
IE910737A1 (en) 1991-09-11
EP0450327A1 (en) 1991-10-09
FI102376B (fi) 1998-11-30
EP0450327B1 (en) 1996-06-05
KR940005657B1 (ko) 1994-06-22
DK0450327T3 (da) 1996-06-24
FI102376B1 (fi) 1998-11-30
YU39391A (sh) 1994-01-20
TW232698B (da) 1994-10-21
KR910016934A (ko) 1991-11-05
PT96943B (pt) 1998-07-31
NO179555B (no) 1996-07-22
CY1941A (en) 1997-05-16
SG63555A1 (en) 1999-03-30
JPH0789981A (ja) 1995-04-04
NO910855L (no) 1991-09-09
FI911047A (fi) 1991-09-07
HUT61601A (en) 1993-01-28
CS9100586A2 (en) 1991-10-15
ATE138926T1 (de) 1996-06-15
DE69119964T2 (de) 1997-02-06
HK181496A (en) 1996-10-04
US5468849A (en) 1995-11-21
CZ279307B6 (cs) 1995-04-12
IL97233A0 (en) 1992-05-25
ES2088439T3 (es) 1996-08-16
HU910716D0 (en) 1991-09-30
GR3020163T3 (en) 1996-09-30
DE69119964D1 (de) 1996-07-11
PT96943A (pt) 1991-10-31
NO910855D0 (no) 1991-03-05
HU211055B (en) 1995-10-30
JPH0780899B2 (ja) 1995-08-30
AU7261691A (en) 1991-09-12

Similar Documents

Publication Publication Date Title
EP0349049B1 (en) Immunosuppressant compound
EP0349061B1 (en) Immunosuppressant agent
EP0388962B1 (en) BMY-41950 antitumor antibiotic
US5468849A (en) Rebeccamycin analogs by tryptophan analogs feeding
US5073633A (en) BMY-41950 antitumor antibiotic
CA2037596C (en) Rebeccamycin analog by bromide precursor feeding
US5158938A (en) Rebeccamycin
EP0378321A2 (en) Microbial transformation product of L-683-590
US5344823A (en) Antitumor antibiotic BMY-41219
CA2037783C (en) Rebeccamycin analogs by tryptophan analogs feeding
US5281417A (en) Antitumor process employing novel fermentate of an Actinomadura strain
US5290772A (en) Immunosuppressant agent
EP0403242A1 (en) New L-683,590 microbial transformation product
EP0329109B1 (en) Antitumor antibiotics
US5036010A (en) BMY-40800 antitumor antibiotics
US5919671A (en) Antitumor antibiotic BMS-199687
EP0657467A1 (en) Antitumor antibiotics

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed